Connection

Jean-Charles Soria to Proportional Hazards Models

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Proportional Hazards Models.
Jean-Charles Soria
Connection Strength
0.075
Proportional Hazards Models
  1. Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited. Cancer Discov. 2021 02; 11(2):233-236.
    View in: PubMed
    Score: 0.022
  2. Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door. Eur J Cancer. 2018 03; 92:1-10.
    View in: PubMed
    Score: 0.018
  3. Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors). Eur J Cancer. 2017 10; 84:202-211.
    View in: PubMed
    Score: 0.017
  4. Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score). Eur J Cancer. 2017 10; 84:212-218.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.